In this chapter we review issues relating to antitrust and competition in health care markets.
The chapter begins with a brief review of antitrust legislation. We then discuss whether and …

This paper reviews the literature on reference pricing (RP) in pharmaceutical markets. The
RP strategy for cost containment of expenditure on drugs is analyzed as part of the …

Diabetes is induced in mice by using streptozotocin (STZ), a compound that has a
preferential toxicity toward pancreatic β cells. We evaluated nude male mice from various …

Medicare Part D began coverage of prescription drugs in 2006. Rather than setting
pharmaceutical prices, the government contracted with private insurers to provide drug …

Die 2. Auflage des Lehrbuchs präsentiert einen umfassenden Ansatz zur Erklärung und
Gestaltung des unternehmerischen Innovationsverhaltens. Das Innovationsmanagement …

We study entry and bidding in procurement auctions where contracts are awarded to the bid
closest to a trimmed average bid. These auctions, common in public procurement, create …

The largest growth in entitlement program spending in the United States over the past fifteen
years has been in the Medicaid program, which provides health insurance to low-income …

Using data on wholesale prices for antibiotics sold to US drugstores, we test the growing
theoretical literature on 'countervailing power'(a term for the ability of large buyers to extract …

Despite the importance of patient insurance in the market for prescription pharmaceuticals,
little is known about the impact of patient reimbursement on the pricing behavior of …

In 2003 the federal-state Medicaid program provided prescription drug coverage to more
than 50 million people. To determine the price that it will pay for each drug, Medicaid uses …